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A major cause of cell death caused by geno-
toxic stress is thought to be due to the depletion
of NAD+ from the nucleus and the cytoplasm.
Here we show that NAD+ levels in mitochondria
remain at physiological levels following geno-
toxic stress and can maintain cell viability
even when nuclear and cytoplasmic pools of
NAD+ are depleted. Rodents fasted for 48 hr
show increased levels of the NAD+ biosynthetic
enzyme Nampt and a concomitant increase in
mitochondrial NAD+. IncreasedNampt provides
protection against cell death and requires an
intact mitochondrial NAD+ salvage pathway as
well as the mitochondrial NAD+-dependent de-
acetylases SIRT3 and SIRT4. We discuss the
relevance of these findings to understanding
how nutrition modulates physiology and to the
evolution of apoptosis.INTRODUCTION
Approximately 2 billion years ago, eukaryotes evolved by
subsuming a bacterial antecedent of modern mitochon-
dria (Barile et al., 1996; Gray et al., 1999). Mitochondria still
retain a variety of molecules that dictate cell survival,
which at one time may have been important for the survival
of the bacterial proto-mitochondrion (James et al., 1998).
Elucidation of these cell survival pathways is considered
key to the development of new approaches to treating
a variety of human diseases including cancer and neuro-
degeneration (Porcu and Chiarugi, 2005).
One of the major causes of cell death due to genotoxic
stress is hyperactivation of the NAD+-dependent enzyme
poly(ADP-ribose) polymerase-1 (PARP-1), which depletes
nuclear and cytoplasmic NAD+ causing the translocationCell 130of apoptosis inducing factor (AIF) from the mitochondrial
membrane to the nucleus (Burkle, 2005; Cipriani et al.,
2005; van Wijk and Hageman, 2005; Yu et al., 2002).
One recent study reported that a fraction of PARP-1 is lo-
calized in mitochondria, which has led to speculation
about the potential for mitochondrial NAD+ to determine
cell fate (Du et al., 2003). Yet little is known about mito-
chondrial NAD+ biosynthesis (Barile et al., 1996; Berger
et al., 2005; Kun et al., 1975), what the actual concentra-
tion of NAD+ is in mitochondria (Di Lisa and Bernardi,
2006), whether mitochondrial NAD+ levels change in re-
sponse to biological stress or diet, and what impact this
has on cell survival and metabolism (Porcu and Chiarugi,
2005; Viswanathan et al., 2005).
The sirtuins are a conserved family of deacetylases and
mono-ADP-ribosyltransferases that use NAD+ as a co-
substrate (Guarente and Picard, 2005). These unusual en-
zymes, which bear virtually no sequence homology to
class I and II HDACs (Denu, 2005; Frye, 2000), have
emerged as key regulators of cell survival and organismal
longevity (Guarente and Picard, 2005). The founding
member of the sirtuin family, Saccharomyces cerevisiae
Sir2, is an NAD+-dependent histone deacetylase that
mediates life span extension by mild stress and calorie re-
striction (CR) (Imai et al., 2000; Lin et al., 2000; Rogina and
Helfand, 2004; Smith et al., 2000; Tanny et al., 1999).
Mammals have seven sirtuins, SIRT1–7. SIRT1, a nuclear
deacetylase, regulates a variety of functions including cell
survival, glucose homeostasis, and fat metabolism (Guar-
ente, 2005). There are three mitochondrial sirtuins, SIRT3–
5. SIRT3 and SIRT4 were recently shown to regulate
acetyl-CoA synthetase 2 (AceCS2) and glutamate de-
hydrogenase, respectively (Haigis et al., 2006; Hallows
et al., 2006; Schwer et al., 2002), but little else is known
about their biological functions.
Increased gene dosage or enhanced activity of Sir2
extends life span in S. cerevisiae, C. elegans, and
D. melanogaster (Anderson et al., 2003; Kaeberlein et al.,
1999; Lin et al., 2000; Rogina and Helfand, 2004;, 1095–1107, September 21, 2007 ª2007 Elsevier Inc. 1095
Tissenbaum and Guarente, 2001; Wood et al., 2004).
Yeast Sir2 is positively regulated by PNC1, a stress- and
calorie-responsive longevity gene that catalyzes the first
and rate-limiting step in NAD+ biosynthesis from nicotin-
amide (NAM) (Anderson et al., 2003; Gallo et al., 2004).
Whether or not mammals possess a functional equivalent
of the PNC1 gene is not known. Clearly, finding a mamma-
lian equivalent of a gene that governs sirtuin activity and
promotes longevity has many potential implications, in-
cluding our understanding of how CR extends life span
in mammals.
The search for a mammalian equivalent of PNC1 has
been complicated by the fact that the synthesis of NAD+
from NAM is different in mammals than in simple eukary-
otes (Brenner, 2005). While yeast, worms, and flies require
four steps to synthesize NAD+ from NAM, mammals re-
quire only two (Rongvaux et al., 2002). In yeast, the first
step is catalyzed by Pnc1 and in mammals by the NAM
phosphoribosyltransferase Nampt, also known as PBEF
or visfatin (Fukuhara et al., 2004; Rongvaux et al., 2002;
Samal et al., 1994). Recent studies have shown that over-
expression of Nampt increases SIRT1 activity (Revollo
et al., 2004) and can protect cells from death due to
PARP overexpression (Pillai et al., 2005), which is consis-
tent with the hypothesis that Nampt is a functional equi-
valent of Pnc1 in mammals.
In this paper, we identify NAMPT as a stress- and nutri-
ent-responsive gene that boosts mitochondrial NAD+
levels. Mass spectrometric methods are used to accu-
rately measure NAD+ concentrations within mammalian
mitochondria and to show that NAMPT expression and
mitochondrial NAD+ levels increase in vivo after fasting.
Evidence is presented that increased mitochondrial
NAD+ promotes cell survival during genotoxic stress and
that protection is provided by the mitochondrial sirtuins
SIRT3 and SIRT4. These data show that mitochondrial
NAD+ is a major determinant of apoptosis and shed new
light on the influence of diet on organ physiology and
disease.
RESULTS
NAMPT Expression Is Induced by Cell Stress
and Nutrient Restriction
Others and we have speculated that mammalian Nampt is
the functional equivalent of yeast Pnc1 (Anderson et al.,
2002, 2003; Bitterman et al., 2003; Revollo et al., 2004;
Yang et al., 2006). This idea was based on the fact that
both Pnc1 and Nampt catalyze the first and rate-limiting
step in NAD+ biosynthesis from NAM (Pillai et al., 2005;
Revollo et al., 2004; Rongvaux et al., 2002).
We reasoned that if NAMPT is analogous to the yeast
PNC1 gene, then its expression might also be induced
by cell stress and nutrient restriction. We found that hu-
man fibrosarcoma HT1080 cells cultured in serum-free
conditions had 1.5- to 2-fold the levels of Nampt relative
to controls (Figure 1A). A similar increase in Nampt at both
the mRNA and protein level was observed in the livers of1096 Cell 130, 1095–1107, September 21, 2007 ª2007 Elsevier Inrats that were subjected to a 48 hr fast (Figures 1B–1D).
Primary cardiomyocytes exposed to hypoxia or serum-
free media also had 2-fold higher levels of Nampt (Fig-
ure 1E). Similar results were observed in primary mouse
embryonic fibroblasts (MEFs) grown in serum-free
medium (data not shown). Thus, NAMPT is a stress- and
nutrient-responsive gene, similar in this regard to the yeast
PNC1 gene.
Nampt Protects against Cell Death
due to Genotoxic Stress
To mimic the upregulation of Nampt and to test what ef-
fect this has on stress resistance, we generated human
Nampt-overexpressing stable cell lines from HT1080
fibrosarcoma and HEK293 embryonic kidney cells and
selected lines that expressed 1.5 to 2 times the level of
Nampt relative to vector controls (Figures 1F and 1H). A
similar increase in Nampt expression was obtained by
transiently transfecting HT1080 cells with a mouse Nampt
expression construct (Figure 1G). Stable Nampt knock-
down cell lines were also generated using siRNA
(Figure 2A).
Cell lines were then assayed for their sensitivity to meth-
ylmethane sulfonate (MMS), a DNA alkylating agent that is
known to hyperactivate PARP-1 (Horton et al., 2005).
MMS treatment resulted in the death of about half the vec-
tor control cells, and the extent of cell death was greatly
reduced by the PARP inhibitor, DPQ (Figure S1 available
with this article online), indicating that PARP hyperactiva-
tion and depletion of NAD+ were the primary modes of
death under these conditions. Although Nampt-overex-
pressing cells had only slightly higher levels of Nampt pro-
tein, they were substantially more resistant to MMS than
controls (Figures 1F–1H). Conversely, cells with lower
levels of Nampt were more sensitive to MMS (Figures 2A
and Figure S2). A potent Nampt catalytic inhibitor,
FK866, which binds in the active site (Drevs et al., 2003),
prevented cell protection by Nampt overexpression
(Figure 2B), indicating that Nampt activity is required for
cell protection.
Given that Nampt levels increase in cells grown in
serum-free media, we wondered whether cells in serum-
free media are more resistant to MMS and, if so, whether
their resistance is mediated by Nampt. As shown in Fig-
ure 2C, cells that were serum starved were more resistant
to MMS, and this resistance was entirely Nampt depen-
dent.
We also tested whether Nampt provides resistance to
cell death from other types of DNA damage. Etoposide
is a cancer chemotherapeutic agent that inhibits topoiso-
merase II, resulting in numerous double-stranded DNA
breaks that trigger apoptosis. Nampt-overexpressing
cells were more resistant to etoposide and had reduced
levels of cleaved caspase 3, a marker of apoptosis (Fig-
ure 2D). Conversely, cells with reduced levels of Nampt
were more sensitive to etoposide and had increased levels
of cleaved caspase 3 (Figure 2E). The Nampt knock-
down cells were also more sensitive to camptothecin, ac.
Figure 1. Nampt Is a Stress- and Nutri-
ent-Responsive Gene that Protects Cells
against the Genotoxic Agent MMS
(A and B) Nampt levels in human fibrosarcoma
HT1080 cells in the presence or absence of
10% FBS (A) or of liver tissue extracts from
fed or 2 day-fasted Sprague-Dawley rats (B).
Actin and tubulin were used as loading con-
trols.
(C and D) Nampt protein (C) and mRNA levels of
Nampt (D) in livers of fasted rats (n = 4; bars
represent the mean of three experiments ±
standard deviations [SD] using Student’s t test).
(E) Western blot of Nampt in primary rat cardio-
myocytes under hypoxia and/or serum starva-
tion.
(F and G) Survival of HT1080 cells stably ex-
pressing human (F) or transiently expressing
mouse Nampt (G) following treatment with
1.2 mM methylmethanesulfonate (MMS).
(H) Survival of human kidney HEK293 cells
stably expressing human Nampt treated with
MMS as in (F).
Always, bars represent the mean of three
experiments ± SD.topoisomerase I inhibitor (Figure 2F), demonstrating that
the ability of Nampt to protect from cell death is not spe-
cific to MMS.Nampt-Mediated Cell Protection Requires
Mitochondrial SIRT3 and SIRT4
In light of a recent study showing that the ability of Nampt
to protect against PARP-1 overexpression was SIRT1 me-
diated (Pillai et al., 2005), we expected that protection
from MMS would be SIRT1 dependent. But neither
EX-527, a SIRT1-specific inhibitor (Solomon et al., 2006),
nor siRNA-mediated knockdown of SIRT1 had a signifi-
cant effect on Nampt-mediated survival (Figures 3A, 3B,
and S3A). Curiously though, treatment of cells with the
pan-sirtuin inhibitor, sirtinol, did block the ability of Nampt
overexpression to protect cells (Figure 3C), which raisedCell 130the possibility that survival might be mediated by another
sirtuin.
To test this idea, we knocked down each of the remain-
ing sirtuins, SIRT2–7, using siRNA (Figures S3A–S3B) and
scored survival after MMS treatment. Interestingly, the mi-
tochondrial sirtuins, SIRT3 and SIRT4, but not the other
sirtuins, were required for the ability of Nampt to protect
against MMS-induced cell death (Figures 3D, 3E, and
S3C–S3F). In addition, knockdown of SIRT3 sensitized
wild-type (WT) cells to MMS and increased the relative
abundance of cleaved caspase 3 (Figures 3D and 3F
and data not shown). This effect appears to be relatively
specific to MMS-induced cell death because there
was no appreciable effect on sensitivity to etoposide
(Figure S4).
These data indicated that overexpression of Nampt
might protect cells by increasing SIRT3 activity. We tested, 1095–1107, September 21, 2007 ª2007 Elsevier Inc. 1097
Figure 2. Nampt Protects against Apo-
ptotic Cell Death Induced by Topoiso-
merase Inhibitors
(A) Sensitivity of HT1080 with siRNA-mediated
knockdown of NAMPT after MMS exposure.
(B) Stable overexpression of Nampt enhances
survival of HEK293 cells following MMS treat-
ment and the effect is blocked by the Nampt-
inhibitor FK866.
(C) Survival of WT or Nampt knockdown
HT1080 cells after serum deprivation for 22 hr
and then exposure to MMS for 17 hr. Serum
deprivation upregulates Nampt and enhances
survival of WT but not Nampt knockdown
HT1080 cells.
(D and E) Survival of HEK293 stably overex-
pressing Nampt (D) or HT1080 with siRNA
knockdown of Nampt (E) following etoposide
treatment.
(F) Survival of HT1080 Nampt knockdown cells
after camptothecin treatment. Apoptosis was
assessed by western blot analysis of cleaved
Caspase-3.
Bars represent the mean of three experiments
± SD.this by monitoring the acetylation status of AceCS2, a sub-
strate of SIRT3. As shown in Figure 3G, Nampt overex-
pression markedly reduced the acetylation level of
AceCS2, indicating that Nampt increases SIRT3 activity.
Knockdown of SIRT4, on the other hand, had no signifi-
cant effect on the survival of WT cells (Figure 3E and
data not shown). There was no significant increase in the
survival of cells overexpressing SIRT3 or SIRT4, or in com-
bination (data not shown), suggesting that in the absence
of additional Nampt, MMS causes NAD+ levels to drop1098 Cell 130, 1095–1107, September 21, 2007 ª2007 Elsevier Inbelow the concentration at which these NAD+-dependent
enzymes can function, a possibility we tested below (see
Figure 5).
Nampt Does Not Prevent Depletion of Total NAD+
It is generally recognized that genotoxic stress kills cells
by depleting nuclear and cytosolic NAD+ pools (Burkle,
2005; Porcu and Chiarugi, 2005). To test whether Nampt
protected against NAD+ depletion, we measured NAD+
concentrations in HEK293 cells after exposure to MMSc.
Figure 3. Nampt-Mediated Protection against Genotoxicity Requires SIRT3 and SIRT4
(A) Survival of HEK293 cells stably expressing Nampt following exposure to MMS in the presence or absence of the SIRT1-specific inhibitor EX-527.
(B) siRNA knockdown of SIRT1 using a pool of four siRNA oligos, compared to nontargeting siRNA controls. Cells were cotransfected with FAM-
tagged fluorescent oligos and percentage cell death was determined by FACS as a ratio of PI/FAM-positive cells versus total FAM-positive cells.
(C) HEK293 cells were treated with 100 mM sirtinol, a pan sirtuin inhibitor. All experiments were carried out three times in triplicate.
(D and E) SIRT3 or SIRT4 was knocked down in HEK293 cells stably overexpressing Nampt using pools of specific siRNA oligos, and cells were then
treated with MMS and scored for survival.
(F) Cells from (D) were probed by western blotting for cleaved caspase-3, an indicator of apoptosis.
(G) Immunoprecipitation (IP) of AceCS2 from cell lysates of control and Nampt-overexpressing HEK293 cells transfected with control vector or
AceCS2-HA for 48 hr. The levels of acetylated AceCS2 in IPs were analyzed by western blotting.
Bars represent the mean of three experiments ± SD.using a quantitative HPLC/mass spectrometry method
(HPLC/MALDI/MS) (Sauve et al., 2005). We did not at-
tempt to measure nicotinamide levels in mitochondria be-
cause, unlike NAD+, it diffuses through membranes (van
Roermund et al., 1995).
An internal NAD+ reference, 18O-NAM, was synthesized
from 3-cyanopyridine, then enzymatically converted to
18O-NAD+ using a recombinant NAD+ glycohydrolase,Cell 130CD38 (Figure 4A). The key advantage of the HPLC/
MALDI/MS technique is that extracts are spiked with an
isotopically labeled NAD+ internal reference standard so
that losses of NAD+ during purification do not affect the
final result. After addition of the labeled standard, the
NAD+ in the cell extracts was HPLC purified and analyzed
by mass spectrometry, which gave two peaks that
corresponded to the two isotopomer molecular ions, 1095–1107, September 21, 2007 ª2007 Elsevier Inc. 1099
Figure 4. Nampt Regulates Total NAD+
(A) Synthesis of isotope-labeled 18O-NAD+, a reference compound used in NAD+ measurement. 18O-NAM was synthesized by hydrolyzing 3-cyano-
pyridine in 18O-H2O and was then used as a substrate in the enzymatic reaction catalyzed by CD38, a NAD
+ glycohydrolase, to generate 18O-NAD+.
(B and C) Total endogenous 16O-NAD+ and spiked-in NAD reference 18O-NAD+ were isolated by HPLC then subjected to MALDI-MS. The ion intensity
of the reference peaks of 18O-NAD+ were normalized to 100 in all cases. The ratio of 16O-NAD+ peaks reflects the relative amount of NAD+ in the two
samples. Experiments were performed at least three times. Total NAD+ spectra from HEK293 are shown for vector controls and cells stably overex-
pressing Nampt (B) as well as total NAD+ spectra from HT1080 vector controls and siRNA-Nampt stable cells (C).
(D) Overexpression of Nampt cannot prevent total cellular NAD+ depletion by MMS as determined by MALDI-MS spectra of endogenous 16O-NAD
and reference 18O-NAD after 2 hr MMS treatment of HEK293 WT and Nampt-overexpressing cells.
(E) Time course of cell death induced by 1.2 mM MMS treatment. Percent cell death was determined by FACS analysis.
(F) Total cellular NAD+ as measured by MALDI-MS during the time course in (E).
Bars represent the mean of three experiments ± SD.(Figure 4B). The higher molecular weight species, 18O-
NAD+, was used to determine the quantity of the lower
weight endogenous species, 16O-NAD+.
We estimate that the total NAD+ concentration in
HEK293 cells is 365 ± 30.2 mM, which is very close to a re-
cent estimate for mouse erythrocytes using HPLC/MS/
electrospray ionization (368 mM) (Yamada et al., 2006).
Interestingly, Nampt-overexpressing cells had approxi-
mately twice the total NAD+ concentration of vector con-
trol cells and, conversely, Nampt knockdown cells had1100 Cell 130, 1095–1107, September 21, 2007 ª2007 Elsevier Inapproximately half (Figures 4B and 4C). These data are
consistent with other studies showing that Nampt cata-
lyzes a rate-limiting step in nucleo-cytoplasmic NAD+ bio-
synthesis (Pillai et al., 2005; Revollo et al., 2004).
Surprisingly, Nampt overexpression did not appreciably
affect MMS-mediated depletion of NAD+ in total cell ex-
tracts (Figure 4D). To ensure that we had not simply cho-
sen an inappropriate time point, total NAD+ levels were
measured at time points just prior to, and during which,
cell protection by Nampt was observed (2 and 4 hr)c.
(Figure 4E). Again, concentrations of total NAD+ became
critically low (total [NAD+] < 100 mM), irrespective of Nampt
levels (Figure 4F).
Nampt-Regulated Mitochondrial NAD+ Levels
Dictate Cell Survival
These data raised an intriguing question: How does
Nampt protect cells from genotoxic stress if not by main-
taining total NAD+ levels? An important clue came from
our observation that protection by Nampt required sirtuins
that reside in mitochondria. The cell lines we were using,
HT1080 and HEK293, possess relatively few mitochondria
compared to highly metabolically active cells such as he-
patocytes and myocytes (Di Lisa and Bernardi, 2006), and
hence mitochondria contribute only a minor component of
the total NAD+ pool of these cells. It was plausible that the
NAD+ remaining in the MMS-treated cells was primarily
mitochondrial and that the increased survival in Nampt
overexpressors was a consequence of increased NAD+
levels in mitochondria.
Surprisingly little is known about the precise concentra-
tion of NAD+ in mammalian mitochondria or whether
changes in mitochondrial NAD+ levels impact cell survival
(Porcu and Chiarugi, 2005; Viswanathan et al., 2005). This
lack of knowledge appears to stem, in part, from the lack
of a robust and accurate method to measure mitochon-
drial NAD+ concentrations. Indeed, only a few studies
have attempted to measure mitochondrial NAD+ levels
by any means. Using enzymatic assays, it has not been
possible to accurately determine actual concentrations
of NAD+ within the organelle. Levels are typically ex-
pressed not in molarity but as a nmol NAD+/mg mitochon-
drial protein (Di Lisa and Bernardi, 2006; Noack et al.,
1992; Tobin et al., 1980).
We began by measuring actual mitochondrial NAD+
concentrations using an adaptation of the MALDI-MS
technique described above (see Experimental Pro-
cedures). We estimate that the concentration of NAD+ in
mitochondria of HEK293 cells is 245.6 mM, corresponding
to 2053 pmol NAD+/mg mitochondrial protein. Consistent
with our hypothesis, cells with additional Nampt had ap-
proximately double the concentration of NAD+ in mito-
chondria (Figure 5A), and there was a corresponding de-
crease in mitochondrial NAD+ in cells in which Nampt
was knocked down (Figure 5B). Importantly, Nampt did
not alter mitochondrial size or number, and losses of
NAD+ during purification post-addition of the NAD+ refer-
ence would not have affected the result.
Next, we determined the effect of Nampt on mitochon-
drial NAD+ after MMS treatment. Strikingly, Nampt-over-
expressing cells had more than double the concentration
of mitochondrial NAD+ relative to MMS-treated WT
controls (Figure 5C). In fact, the concentration of mito-
chondrial NAD+ in Nampt-overexpressing cells was higher
during MMS exposure than that in WT cells that were
untreated. Thus, mitochondria of Nampt-overexpressing
cells retain physiological levels of NAD+ after MMS treat-
ment, even if the rest of the cell is depleted of NAD+.Cell 130How Do Mitochondria Maintain NAD+ and Protect
Cells from Apoptosis?
Next, we wondered how mitochondria maintain such high
NAD+ levels during genotoxic stress. There were two plau-
sible explanations. Mitochondria might possess an en-
dogenous NAD+ biosynthetic pathway and/or they might
import NAD+ from the cytosol. We first tested the hypoth-
esis that Nampt is localized to mitochondria and partici-
pates in mitochondrial NAD+ synthesis. There is already
good evidence for an NAD+ salvage pathway in mitochon-
dria. Two studies showed that an NAD+ precursor can be
converted to NAD+ when added to mitochondrial prepara-
tions (Barile et al., 1996; Kun et al., 1975), and, more re-
cently, an enzyme immediately downstream of Nampt in
the NAD+ salvage pathway, Nmnat3 (for NAMmononucle-
otide adenylyltransferase), was shown to be exclusively
mitochondrial (Berger et al., 2005).
To explore whether mitochondria contain Nampt, we
isolated highly pure mitochondrial fractions from either
HEK293 cells (Figure 5D) or fresh rat livers, in the latter
case using two different mitochondrial isolation methods
(Figure 5E). The purity of the fractions was assessed by
probing for cytoplasmic markers (Hsp90, calreticulin, lac-
tate dehydrogenase), mitochondrial matrix markers
(CoxIV or cytochrome c), and a nuclear membrane protein
(lamin A/C). The enrichment of mitochondrial markers in
the mitochondrial fractions and the absence of cytoplas-
mic and nuclear proteins in these fractions demonstrated
that the mitochondrial preparations were highly pure.
Nampt was observed in cytoplasmic and nuclear frac-
tions, consistent with other reports (Kitani et al., 2003;
Revollo et al., 2004; Rongvaux et al., 2002). In all of the
mitochondrial preparations, from HEK293 cells and from
liver tissue, Nampt was clearly detected. Nampt was
also present in highly pure mitochondrial preparations
from human lymphoblasts, HepG2 hepatocarcinoma
cells, and HeLa cells (data not shown).
To add weight to these findings, we performed func-
tional assays for Nampt activity in mitochondria. Specifi-
cally, we tested whether interfering with Nampt activity
in mitochondria affects mitochondrial NAD+ levels and
whether blocking mitochondrial NAD+ biosynthesis re-
duced the ability of Nampt to protect from genotoxic
stress. First we reasoned that if Nampt activity is required
to maintain mitochondrial NAD+, then inhibiting Nampt
in isolated mitochondria should reduce mitochondrial
NAD+ levels. On the other hand, if mitochondrial NAD+
is derived from the cytoplasm, then inhibiting Nampt
activity should have no effect on the levels of NAD+ in
purified mitochondria.
Mitochondria from fresh rat livers were purified and
treated in vitro with MMS or FK866 or in combination
(Figure 5F). NAD+ content in the mitochondria was then
determined using the HPLC/mass spectrometry method
utilized above for whole cells. Treatment of isolated mito-
chondria with MMS reduced mitochondrial NAD+ levels by
2-fold (Figure 5G), similar to the effect of treating whole
cells with MMS and consistent with hyperactivation of, 1095–1107, September 21, 2007 ª2007 Elsevier Inc. 1101
Figure 5. Mammalian Mitochondria Maintain Mitochondrial NAD+ Levels during Genotoxic Stress
(A and B) Nampt regulates mitochondrial NAD+ levels. Mitochondrial NAD+ was isolated and analyzed as described in Figures 4B and 4C. Spectra
from HEK293 are shown for vector controls and cells stably overexpressing Nampt (A), as well as spectra from HT1080 vector controls and siRNA-
Nampt stable cells (B).
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Figure 6. Fasting Increases Hepatic
Mitochondrial NAD+ and Nampt Levels
(A) Overexpression of Nampt in HEK293 cells
inhibits the localization of AIF to the nucleus
after MMS treatment for the times indicated,
as assessed by western blotting.
(B) Western blotting analysis of Nampt in mito-
chondria from rats fed AL or fasted for 48 hr.
(C) Relative mitochondrial NAD+ levels in liver
tissues from rats fed AL or fasted for 48 hr.
Mitochondrial NAD+ levels were measured by
MALDI-MS. Bars represent the mean of three
experiments ± SD.intra-mitochondrial PARP-1 (Du et al., 2003). Treatment of
isolated mitochondria with FK866, with or without MMS,
resulted in even larger decreases in mitochondrial NAD+
levels. Similar decreases in NAD+ were observed after
treatment of mitochondria prepared by an alternative
method (Figure S5). These data indicated that mitochon-
dria possess an NAD+ salvage pathway and that inhibition
of Nampt in the organelle results in decreased NAD+.
As a further test, we determined whether the protection
provided by Nampt required an intact mitochondrial NAD+
salvage pathway. During the course of these experiments,
we were fortunate that an exclusively mitochondrial NAD+
biosynthetic enzyme, Nmnat-3, was discovered (Berger
et al., 2005). We reasoned that if Nampt boosts cell sur-
vival by increasing the synthesis of NAD+ in mitochondria
rather than in the cytoplasm or the nucleus, then knocking
down Nmnat-3 should diminish Nampt-mediated protec-
tion against MMS. If not, then knocking down Nmnat-3
should have no effect on cell protection.
Nmnat-3 was knocked down 40% using an siRNA
construct in HEK293 cells expressing a stably integrated
Nampt construct (Figure S6). Cells were then tested for re-
sistance to MMS. As shown in Figure 5H, knockdown of
Nmnat-3 significantly reduced Nampt-mediated protec-
tion against MMS, demonstrating that a complete mito-
chondrial NAD+ salvage pathway is necessary for Nampt
to provide resistance to MMS. No protection from MMS
was seen by overexpressing Nmnat-3 (data not shown),
which is in accordance with reports that overexpressing(C) Additional Nampt greatly attenuates mitochondrial NAD+ depletion by MM
HEK293 WT and Nampt-overexpressing cells.
(D and E) Western blotting analysis of Nampt in highly purified cytosolic an
HEK293 cells or from rat livers using two different protocols, and their purity
drogenase (exclusively cytoplasmic proteins), and CoxIV or cytochromeC (mi
test for contamination of the mitochondrial fractions with nuclei. The experime
same pattern was observed each time and representative blots are shown.
(F) Mitochondria from rat livers were prepared and exposed to methylmetha
inhibitor FK866, or both. NAD+ levels in isolated mitochondria were determin
(G) NAD+ levels in isolated mitochondria are reduced by exposure to MMS a
isolation protocol (see Figure S5).
(H) Knocking down expression of Nmnat-3 reduces the ability of Nampt to p
(I) Knocking down expression of a putative human mitochondrial NAD+ trans
treated with MMS.
Bars represent the mean of three experiments ± SD.
Cell 130the cytoplasmic form of Nmnat (Nmnat-1) has no effect
on NAD+ levels (Araki et al., 2004; Revollo et al., 2004).
The alternative hypothesis, that Nampt increases
mitochondrial NAD+ by promoting NAD+ import from the
cytoplasm, seemed less likely given our observation that
mitochondria retain higher NAD+ levels than the cyto-
plasm during MMS treatment. Nevertheless, we searched
for evidence of a mammalian mitochondrial NAD+ trans-
porter. Although mitochondrial NAD+ transport has not
been described for mammals, two mitochondrial NAD+
transporters were recently discovered in S. cerevisiae
(Todisco et al., 2006). We identified a putative human
homolog called hMFT (identity = 35% to yeast Ndt1;
accession NM_030780; Figure S7A). Knocking down of
hMFT did not, however, affect the ability of Nampt to pro-
tect from MMS (Figures S7B and 5I). We cannot rule out
the possibility that another NAD+ transporter exists
and that mitochondria can import NAD+ from the cyto-
plasm, but, taken together, we believe that the simplest
explanation of the data is that Nampt is active in mito-
chondria.
It is generally accepted that depletion of NAD+ stimu-
lates a number of proapoptotic pathways, including the
relocalization of AIF from the outer mitochondrial mem-
brane to the nucleus (Di Lisa and Bernardi, 2006; Porcu
and Chiarugi, 2005; Yu et al., 2002). As shown in Figure 6A,
Nampt overexpression suppressed translocation of AIF
to the nucleus in response to MMS, demonstrating that
Nampt lies upstream of this major apoptotic pathway.S treatment, as determined by MALDI-MS after 2 hr MMS treatment of
d mitochondrial fractions. Mitochondiral fractions were isolated from
was assessed by probing for Hsp90, calreticulin, and/or lactate dehy-
tochondrial matrix markers). The same blot was probed for lamin A/C to
nt was performed three times on HEK293 cells and on liver tissue. The
ne sulfonate (MMS), a genotoxic DNA alkylating agent, or the Nampt
ed using MALDI-MS, as above.
nd FK866. Similar data were obtained using a different mitochondrial
rovide resistance to MMS.
porter, hMFT, does not affect survival of Nampt-overexpressing cells
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Fasting Increases Mitochondrial Nampt and NAD+
In Vivo
Finally, we tested whether these data were relevant to the
in vivo situation. If our hypothesis that Nampt is a nutrient-
responsive regulator of mitochondrial NAD+ is correct, we
should observe increased levels of Nampt in the mito-
chondria of fasted rats, concomitant with increased levels
of mitochondrial NAD+. To our knowledge, in vivo changes
in mitochondrial NAD+ have not been examined previ-
ously. Rats were fasted 48 hr, their livers excised, and
mitochondria were purified as described above. Mito-
chondrial fractions were divided for western blotting and
for NAD+ determinations using HPLC/MS. After the 48 hr
fast there was a dramatic rise in Nampt levels in the mito-
chondrial fractions (Figure 6B), and there was a concomi-
tant increase in mitochondrial NAD+ levels in the mito-
chondrial extracts from the fasted animals (Figure 6C).
Thus, our results in cell culture extrapolate meaningfully
to the in vivo situation.
DISCUSSION
The importance of mitochondrial function to the rate of
progression of age-related diseases such as cancer, dia-
betes, and neurodegeneration has become increasingly
apparent in recent years (Lin et al., 2005; St-Pierre et al.,
2006). Yet little is currently known about the intracellular
concentration of NAD+ in mitochondria, whether it fluctu-
ates in response to diet, or whether these changes influ-
ence key cellular functions such as apoptosis. In this
study, we have accurately determined NAD+ concentra-
tions in mammalian mitochondria, identified mitochondrial
NAD+ as a determinant of cell survival, and shown that mi-
tochondrial NAD+ levels are dramatically upregulated by
nutrient restriction in vitro and in vivo. One of the more sur-
prising findings of the study was the observation that
mitochondria can maintain physiological levels of NAD+
during genotoxic stress and promote cell survival, even
if NAD+ in the cytoplasm and nucleus has fallen well below
normal physiological levels. We refer to the ability of
mitochondria to dictate cell survival as the ‘‘Mitochondrial
Oasis Effect.’’
This study also shows that Nampt is a stress- and diet-
responsive regulator of mitochondrial NAD+ in mammalian
cells. The data strongly suggest that Nampt is both pres-
ent and functional within mitochondria, directly upstream
of the exclusively mitochondrial NAD+ biosynthetic en-
zyme Nmnat-3. Although we cannot and do not rule out
other mechanisms by which mitochondria obtain NAD+,
such as NAD+ import or via alternative NAD+ biosynthetic
routes (Bieganowski and Brenner, 2004), the fact that
Nampt activity is required to maintain NAD+ levels in iso-
lated mitochondria is strong evidence that Nampt plays
a functional role within these organelles. Given the central
role of Nampt in NAD+ biosynthesis, it is likely that Nampt
activity is not simply regulated at the gene expression level
but at multiple levels, including by substrate availability
and potentially by posttranslational modification.1104 Cell 130, 1095–1107, September 21, 2007 ª2007 Elsevier InConsidering that numerous enzymes in mitochondria
are limited by NAD+ availability, including the sirtuins
SIRT3 and SIRT4, which are known to regulate GDH and
AceCS2, respectively, it will be interesting to explore the
potential impact of mitochondrial NAD+ levels on the
metabolism and health of various organs. Perhaps diet-
induced increases in mitochondrial NAD+ contribute to
not only the increased resistance of calorie-restricted
rodents to toxins but also the changes in fatty-acid metab-
olism and respiration that occur with reduced caloric
intake (Ando et al., 2002; Campisi, 2003; Higami and
Shimokawa, 2000; Migliaccio et al., 1999; Zhang and
Herman, 2002).
The events that lead to PARP-induced apoptosis re-
main poorly understood, but it is known that AIF relocali-
zation is a key event (Di Lisa and Bernardi, 2006; Yu
et al., 2002). In this study, we find that overexpression of
Nampt leads to an attenuation of AIF relocalization. Given
that NAMPT lies upstream of AIF, it will be interesting to
test whether SIRT3 or SIRT4 associate with and/or modify
AIF or other determinants of apoptosis such as the perme-
ability transition pore (PTP).
Our observation that Nampt is a stress- and nutrient-
responsive gene that promotes cell survival via SIRT3
and SIRT4 lends further support to the hypothesis that
NAMPT is a functional homolog of the yeast PNC1 longev-
ity gene (Anderson et al., 2003; Bitterman et al., 2003).
Transgenic mouse experiments are in progress to deter-
mine the effect of overexpressing NAMPT. We hypothe-
size that these animals might have increased resistance
to cell stress, altered metabolism, and disease resistance
(North and Sinclair, 2007).
Because NAD+ is such an ancient molecule, insights
into the biology of NAD+ can provide clues about the early
evolution of life on earth (Brenner, 2005). There is evidence
that cells have used NAD+ as a nutrient sensor that dic-
tates survival for a very long time, possibly predating the
evolution of eukaryotes. Homologs of Nampt and Sir2
are found in bacterial relatives of mitochondria (Smith
et al., 2000), and increased NAD+ levels provide bacterial
resistance to heat, salt stress, and glucose restriction, for
reasons that are not yet clear (Foster et al., 1990). A phy-
logenetic comparison of NAM-metabolizing enzymes
from various species shows that vertebrates utilize a path-
way more closely related to the organisms that gave rise
to the first mitochondria (Andersson et al., 2003) than to
S. cerevisiae, C. elegans, andD.melanogaster (Figure S8).
This indicates that NAD+ levels may have controlled cell
survival in the bacteria that gave rise to mitochondria,
and these survival pathways have been conserved up to
the present day in mammals.
In summary, we have shown that mitochondrial NAD+
levels influence cell survival following genotoxic stress
and that these levels are considerably higher after nutrient
deprivation. We hope that these insights into the impor-
tance of mitochondrial NAD+ will facilitate a new under-
standing of and the development of novel approaches to
treating diseases such as cancer and neurodegeneration.c.
EXPERIMENTAL PROCEDURES
Cell Culture
Human embryonic kidney (HEK293) and human fibrosarcoma HT1080
cell lines were obtained from ATCC and grown in complete DMEM
medium with 10% FBS and 100 mg/ml penicillin/streptomycin. To gen-
erate Nampt overexpression or empty vector stable clones, hNAMPT/
pcDNA or pcDNA empty vector were transfected into HEK293 or
HT1080 cells and selected with 0.5–1.0 mg/ml geneticin. To generate
Nampt knockdown cells, siRNA/NAMPT/pMSCV or pMSCV empty
vector were transfected into HT1080 cells, and stable clones were se-
lected with 500 ng/ml puromycin. Primary neonatal rat cardiomyocytes
were prepared as described previously (Matsui et al., 1999). Isolated
cardiomyocytes were grown in complete medium (RPMI 1640, 5% fe-
tal calf serum, 10% horse serum) to 80% confluence before cells were
subjected to hypoxia and/or serum starvation. For hypoxia, medium
was changed to RPMI 1640 with or without serum saturated with
95% N2/5% CO2, and then cells were placed in a 37
C airtight box sat-
urated with 95% N2/5% CO2 for 18 hr. O2 concentrations were <0.1%
(Ohmeda oxygen monitor, type 5120). To serum starve HT1080, cells
were grown in DMEM medium containing no serum. Cells were
harvested after 26 hr of serum starvation and Nampt expression was
analyzed by western blotting.
Drug Treatments and Cell Death Assays
HEK293 and HT1080 cells at less than 85% confluency were treated
with MMS (1.2 mM) for 6–8.5 hr and 8–17 hr, respectively. Transiently
transfected cells were washed three times with PBS to remove residual
transfection reagents before treating with MMS. HEK293 cells and
HT1080 cells were exposed to etoposide for 72 hr or 46 hr at 120 or
40 mM, respectively. HT1080 cells were exposed to camptothecin at
14 mM for 23 hr. After drug treatments, cells were harvested by trypsi-
nization, pelleted by centrifugation, and resuspended in PBS contain-
ing 3% FBS. Cell death was analyzed by FACS using propidium iodide
(PI) staining. In cells transiently transfected with mNAMPT/MSCV,
SIRT1–7 siRNA, Nmnat-3, or hMFT siRNA oligos and cotransfected
with FAM-labeled scrambled siRNA oligos, percent cell death was de-
termined as the proportion of PI/GFP- or PI/FAM-positive cells versus
the total number of cells with green fluorescence.
Assay for Aceylated AceCS2
Control and Nampt overexpressing HEK293 cells were transfected
with control vector or AceCS2-HA. Forty-eight hours post-transfec-
tions, cells were washed and lysed in IP lysis buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-50, 400 nM TSA,
5 mM Nicotinamide, and protease inhibitors [Compelete, Roche]) for
30 min at 4C. Lysates were cleared and subjected to immunoprecip-
itation with anti-HA affinity gel (Roche) for 2 hr at 4C. Immunoprecip-
itations were washed three times for 15 min each in lysis buffer and
resuspended in 13 SDS-PAGE buffer and analyzed by western
blotting.
Cell Fractionation and Drug Treatment of Mitochondria
Unless otherwise stated, fractionation of cultured cells was performed
using a differential centrifugation and sucrose gradient procedure with
slight modifications (Schwer et al., 2002). For drug treatment of mito-
chondria, fresh mitochondria were obtained from livers excised from
fed young male rats. Half of the liver homogenate was used for mito-
chondrial isolation using a commercially available kit as described by
manufacturer’s instructions, designated Protocol 1 (Pierce Mitochon-
drial Isolation kit, Rockford, IL). The other half of the original homoge-
nate was subjected to a differential centrifugation protocol to isolate
mitochondria (Protocol 2). Mitochondria (500 ml) were added to a
48-well plate and treated with methylmethane sulfonate (MMS) at
1:1000 dilution and/or FK866 (10 nM) for 30 min at 37C. Suspensions
were spun down for 1 min at 14,000 rpm at 4C and pellets were storedCell 130at 80C prior to NAD+ analysis by HPLC/MALDI/MS. Detailed proto-
cols are described in the Supplemental Data.
HPLC/MALDI/MS Determination of NAD+
NAD+ was determined as described previously (Sauve and Schramm,
2003), with the following modifications. HEK293 or HT1080 cells were
harvested by trypsinization and counted by haemocytometer. NAD+
was extracted from whole cells or mitochondrial pellets by adding
10% perchloric acid and sonicating for 5 min on ice. The reference
standard 18O-NAD+ (typically 613.4 pmol) was then added to the sam-
ple. After mixing well, samples were centrifuged for 3 min then neutral-
ized with NaOH. NAD+ in the supernatant (100 ml sample) was sepa-
rated from other cellular components by HPLC. NAD+ peaks were
collected according to the standards’ retention time and dried with
a lyophilizor. MALDI-MS was used to determine the peak ratio
between the positively charged isotopically distinct ions, and the inten-
sities of the 16O- and 18O-peaks were ratioed (664/666) to obtain 16O
NAD+/18O NAD+ in the sample. Standards containing only 16O and
18O NAD+ (600 pmol each) were also run to determine corrections
for isotopic purity and to provide calibration of the procedure. The vol-
ume of mitochondrial pellets was calculated by considering the density
of the mitochondria pellets to be 1.0 ml/mg. Total cellular NAD+ con-
centrations were calculated by dividing the quantity of NAD+ per cell
by the mean cell volume (MCV) as measured by a Coulter counter,
which for HT1080 was 2183.95 fl and for HEK293 was 1691.04 fl.
Animal Experiments
To assess Nampt expression in vivo, Sprague-Dawley rats (120–150 g)
were obtained from Charles River Laboratories and randomly assigned
to control and experimental groups of four animals. The control group
was fed ad libitum (AL) with a 78% sucrose diet prepared by Research
Diets Inc. and the experimental group was fasted for 48 hr before being
sacrificed. Liver tissue for RNA extraction was stored in RNAlater re-
agent (QIAGEN). All other samples were frozen in liquid nitrogen and
stored at 80C until use. To assess mitochondrial Nampt and NAD+
levels, Male Fischer-344 (F344) rats were bred and reared in a vivarium
at the Gerontology Research Center (GRC, Baltimore, MD). From
weaning (2 weeks), the rats were housed individually in standard plas-
tic cages with beta chip wood bedding. Control animals were fed
a NIH-31 standard diet AL. The procedures for preparation of mito-
chondria from liver are described in the Supplemental Data.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
eight figures, and Supplemental References and can be found with
this article online at http://www.cell.com/cgi/content/full/130/6/1095/
DC1/.
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